š”š²šš š¦ššŗšŗš®šæš
⢠Lupin Limited has secured tentative approval from the US FDA for its generic version of Uptravi for Injection, 1800 mcg/vial.
⢠The approval will allow the company to market the product, which is used to treat pulmonary arterial hypertension, in the US.
⢠Lupin also received a positive inspection report from the US health regulator for its manufacturing facility in Madhya Pradesh.